15Aug 2021
Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short‐ and long‐acting glucagon‐like peptide‐1 receptor agonists in type 2 diabetes

Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short‐ and long‐acting glucagon‐like peptide‐1 receptor agonists in type 2 diabetes

To clarify the distinct effects of a long‐acting (liraglutide) and a short‐acting (lixisenatide) glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) on macronutrient intake, gastrointestinal side effects and pancreas function. Fifty participants were randomized to either lixisenatide or liraglutide for a treatment period of 10 weeks. Appetite, satiety, macronutrient intake, gastrointestinal symptoms and variables related to pancreatic function and gastric emptying were assessed at baseline and after treatment...

  • #endo-diabetology

Like

Save

Share